Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging

Biotechnology Advances

Volumn 32, Issue 2, 2014, Pages 269-279

  Cousins, Aidan ^a   Thompson, Sarah K ^b   Wedding, A Bruce ^a   Thierry, Benjamin ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cancer diagnostic; Imaging; Metastasis; MRI; Nanotechnology; Nuclear medicine; PET; Prognostic

Indexed keywords

BODY FLUIDS; IMAGING TECHNIQUES; MAGNETIC RESONANCE IMAGING; MAPPING; NANOTECHNOLOGY; NUCLEAR MEDICINE; POLYETHYLENE TEREPHTHALATES; TUMORS;

CANCER DIAGNOSTICS; CLINICAL APPLICATION; CONVENTIONAL TECHNIQUES; CURRENT LIMITATION; METASTASIS; PROGNOSTIC; SENTINEL LYMPH NODES; TARGETED CONTRAST AGENTS;

DISEASES;

CANCER; DETECTION METHOD; IDENTIFICATION METHOD; LIMITING FACTOR; LITERATURE REVIEW; MAPPING METHOD; TUMOR; X-RAY;

CONTRAST MEDIUM; TRACER;

ANIMAL; CANCER DIAGNOSTIC; DIAGNOSTIC IMAGING; HUMAN; IMAGING; LYMPH NODE; METASTASIS; METHODOLOGY; MOLECULAR IMAGING; MOUSE; NANOMEDICINE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PATHOLOGY; PET; PROGNOSTIC; REVIEW; SENTINEL LYMPH NODE BIOPSY; SWINE;

CANCER DIAGNOSTIC; IMAGING; METASTASIS; MRI; NANOTECHNOLOGY; NUCLEAR MEDICINE; PET; PROGNOSTIC;

ANIMALS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; LYMPH NODES; MICE; MOLECULAR IMAGING; NANOMEDICINE; NEOPLASM METASTASIS; RADIOACTIVE TRACERS; SENTINEL LYMPH NODE BIOPSY; SWINE;

EID: 84895479714     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2013.10.011     Document Type: Review

References (128)

1. Aarsvold J.N., Alazraki J.P. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005, 35:116-128.
2. Agarwal A., Huang S.W., O'Donnell M., Day K.C., Day M., Kotov N., et al. Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging. J Appl Phys 2007, 102.
3. Albertini J.J., Cruse C.W., Rapaport D., Wells K., Ross M., DeConti R., et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996, 223:217-224.
4. Albertini J.J., Lyman G.H., Cox C., Yeatman T., Balducci L., Ku N.N., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996, 276:1818-1822.
5. Alex J.C., Krag D.N. Gamma-probe guided localization of lymph nodes. Surg Oncol Oxford 1993, 2:137-143.
6. Amiri H., Mahmoudi M., Lascialfari A. Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent. Nanoscale 2011, 3:1022-1030.
7. Anzai Y., Piccoli C.W., Outwater E.K., Stanford W., Bluemke D.A., Nurenberg P., et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003, 228:777-788.
8. Balch C.M., Soong S.J., Gershenwald J.E., Thompson J.F., Reintgen D.S., Cascinelli N., et al. Melanoma of the skin. AJCC Cancer 2010, 325-344. [SMNYS]. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
9. Ball C.G., Sutherland F., Kirkpatrick A.W., Dixon E., MacLean A.R., Mack L.A., et al. Dramatic innovations in modern surgical subspecialties. Can J Surg 2010, 53:335-341.
10. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999, 144:789-801.
11. Barrington S.F., O'Doherty M.J. Limitations of PET for imaging lymphoma. Eur J Nucl Med Mol Imaging 2003, 30:S117-S127.
12. Bembenek A., Gretschel S., Schlag P.M. Sentinel lymph node biopsy for gastrointestinal cancers. J Surg Oncol 2007, 96:342-352.
13. Bertrand N., Leroux J.-C. The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release 2012, 161:152-163.
14. Boote E., Fent G., Kattumuri V., Casteel S., Katti K., Chanda N., et al. Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography. Acad Radiol 2010, 17:410-417.
15. Bustos M.E.F., Camargo J.J.P., Resin Geyer G., Feijo Andrade C. Intraoperative detection of sentinel lymph nodes using Patent Blue V in non-small cell lung cancer. Minerva Chir 2008, 63:29-36.
16. Carter C.L., Allen C., Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast-cancer cases. Cancer 1989, 63:181-187.
17. Chien C.-C., Wang C.H., Wang C.L., Li E.R., Lee K.H., Hwu Y., et al. Synchrotron microangiography studies of angiogenesis in mice with microemulsions and gold nanoparticles. Anal Bioanal Chem 2010, 397:2109-2116.
18. Chung Y.E., Hyung W.J., Kweon S., Lim S.-J., Choi J., Lee M.H., et al. Feasibility of interstitial CT lymphography using optimized iodized oil emulsion in rats. Invest Radiol 2010, 45:142-148.
19. Cong L., Takeda M., Hamanaka Y., Gonda K., Watanabe M., Kumasaka M., et al. Uniform silica coated fluorescent nanoparticles: synthetic method, improved light stability and application to visualize lymph network tracer. PLoS One 2010, 5:e13167.
20. Corot C., Robert P., Idee J.-M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006, 58:1471-1504.
21. Crippa F., Leutner M., Belli F., Gallino F., Greco M., Pilotti S., et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med 2000, 41:1491-1494.
22. Cserni G., Bianchi S., Boecker W., Decker T., Lacerda M., Rank F., et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2004, 103:358-367.
23. Cserni G., Bianchi S., Vezzosi V., van Diest P., van Deurzen C., Sejben I., et al. Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer 2008, 44:2185-2191.
24. Dassler K., Roohi F., Lohrke J., Ide A., Remmele S., Huetter J., et al. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles. Invest Radiol 2012, 47:383-391.
25. de Boer M., van Deurzen C.H.M., van Dijck J., Borm G.F., van Diest P.J., Adang E.M.M., et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009, 361:653-663.
26. Eck W., Nicholson A.I., Zentgraf H., Semmler W., Bartling S. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in x-ray computed tomography of live mice. Nano Lett 2010, 10:2318-2322.
27. Ferrone C.R., Panageas K.S., Busam K., Brady M.S., Coit D.G. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 2002, 9:637-645.
28. Fohn L.E., Rodriguez A., Kelley M.C., Ye F., Shyr Y., Stricklin G., et al. D2-40 lymphatic marker for detecting lymphatic invasion in thin to intermediate thickness melanomas: association with sentinel lymph node status and prognostic value-A retrospective case study. J Am Acad Dermatol 2011, 64:336-345.
29. Frangioni J.V. New technologies for human cancer imaging. J Clin Oncol 2008, 26:4012-4021.
30. Fujiwara M., Mizukami T., Suzuki A., Fukamizu H. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aesthet Surg 2009, 62:E373-E378.
31. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002, 2:683-693.
32. Gershenwald J.E., Ross M.I. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med 2011, 364:1738-1745.
33. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast-cancer. Ann Surg 1994, 220:391-401.
34. Goesmann H., Feldmann C. Nanoparticulate functional materials. Angew Chem Int Ed 2010, 49:1362-1395.
35. Grotenhuis B.A., Wijnhoven B.P.L., van Marion R., van Dekken H., Hop W.C., Tilanus H.W., et al. The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 2009, 138:608-612.
36. Guimaraes A.R., Tabatabei S., Dahl D., McDougal W.S., Weissleder R., Harisinghani M.G. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 2008, 71:708-712.
37. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
38. Hara T., Kosaka N., Shinoura N., Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 1997, 38:842-847.
39. Harisinghani M.G., Weissleder R. Sensitive, noninvasive detection of lymph node metastases. PLoS Med 2004, 1:202-209.
40. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003, 348:2491-U5.
41. Harisinghani M.G., Saksena M.A., Hahn P.F., King B., Kim J., Torabi M.T., et al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?. Am J Roentgenol 2006, 186:144-148.
42. Hayashi H., Tangoku A., Suga K., Shimizu K., Ueda K., Yoshino S., et al. CT lymphography-navigated sentinel lymph node biopsy in patients with superficial esophageal cancer. Surgery 2006, 139:224-235.
43. Hermanek P., Hutter R.V.P., Sobin L.H., Wittekind C. Classification of isolated tumor cells and micrometastasis. Cancer 1999, 86:2668-2673.
44. Hiraiwa K., Ueda M., Takeuchi H., Oyama T., Irino T., Yoshikawa T., et al. Sentinel node mapping with thermoresponsive magnetic nanoparticles in rats. J Surg Res 2012, 174:48-55.
45. Hirche C., Murawa D., Mohr Z., Kneif S., Huenerbein M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 2010, 121:373-378.
46. Hutteman M., Mieog J.S.D., van der Vorst J.R., Liefers G.J., Putter H., Lowik C., et al. Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 2011, 127:163-170.
47. Hyung W.J., Kim Y.S., Lim J.S., Kim M.-J., Noh S.H., Kim K.W. Preoperative imaging of sentinel lymph nodes in gastric cancer using CT lymphography. Yonsei Med J 2010, 51:407-413.
48. Jain R., Dandekar P., Patravale V. Diagnostic nanocarriers for sentinel lymph node imaging. J Control Release 2009, 138:90-102.
49. Jamieson G.G., Thompson S.K. Detection of lymph node metastases in oesophageal cancer. Br J Surg 2009, 96:21-25.
50. Jimenez I.R., Roca M., Vega E., Luisa Garcia M., Benitez A., Bajen M., et al. Particle sizes of colloids to be used in sentinel lymph node radiolocalization. Nucl Med Commun 2008, 29:166-172.
51. Johnson L., Charles-Edwards G., Douek M. Nanoparticles in sentinel lymph node assessment in breast cancer. Cancers 2010, 2:1884-1894.
52. Jun Y., Huh Y., Choi J., Lee J., Song H., Kim S., et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 2005, 127:5732-5733.
53. Kaur S., Venktaraman G., Jain M., Senapati S., Garg P.K., Batra S.K. Recent trends in antibody-based oncologic imaging. Cancer Lett 2012, 315:97-111.
54. Kievit F.M., Stephen Z.R., Veiseh O., Arami H., Wang T., Lai V.P., et al. Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs. ACS Nano 2012, 6:2591-2601.
55. Kim J., Lee J., Chang E., Kim S., Suh K., Sul J., et al. Selective sentinel node plus additional non-sentinel node biopsy based on an FDG-PET/CT scan in early breast cancer patients: single institutional experience. World J Surg 2009, 33:943-949.
56. Kitagawa Y., Fujii H., Mukai M., Kubo A., Kitajima M. Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res 2005, 127:123-139.
57. Kitayama J., Ishigami H., Ishikawa M., Yamashita H., Soma D., Miyato H., et al. Hyaluronic acid is a useful tool for intraoperative sentinel node detection in gastric cancer surgery. Surgery 2007, 141:815-820.
58. Kobayashi H., Kawamoto S., Bernardo M., Brechbiel M.W., Knopp M.V., Choyke P.L. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 2006, 111:343-351.
59. Kou G., Wang S., Cheng C., Gao J., Li B., Wang H., et al. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection. Biochem Biophys Res Commun 2008, 374:192-197.
60. Koyama T., Shimura M., Minemoto Y., Nohara S., Shibata S., Iida Y., et al. Evaluation of selective tumor detection by clinical magnetic resonance imaging using antibody-conjugated superparamagnetic iron oxide. J Control Release 2012, 159:413-418.
61. Krag D.N., Weaver D.L., Alex J.C., Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph-node in breast-cancer using a gamma-probe. Surg Oncol Oxford 1993, 2:335-340.
62. Krag D.N., Anderson S.J., Julian T.B., Brown A.M., Harlow S.P., Costantino J.P., et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010, 11:927-933.
63. Landi G., Polverelli M., Moscatelli G., Morelli R., Landi C., Fiscelli O., et al. Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases. J Eur Acad Dermatol Venereol 2000, 14:35-45.
64. Lee J.H., Huh Y.M., Jun Y., Seo J., Jang J., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
65. Leong S.P., Zuber M., Ferris R.L., Kitagawa Y., Cabanas R., Levenback C., et al. Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol 2011, 103:518-530.
66. Leong S.P.L., Kim J., Ross M., Faries M., Scoggins C.R., Metz W.L.R., et al. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol 2011, 18:961-969.
67. Lerman H., Lievshitz G., Zak O., Metser U., Schneebaum S., Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med 2007, 48:201-206.
68. Liptay M.J., Masters G.A., Winchester D.J., Edelman B.L., Garrido B.J., Hirschtritt T.R., et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000, 70:384-389.
69. Liu T.Q., Cousins A., Chien C.C., Kempson I., Thompson S., Hwu Y., et al. Immunospecific targeting of CD45 expressing lymphoid cells: towards improved detection agents of the sentinel lymph node. Cancer Lett 2013, 328:271-277.
70. Luciani A., Itti E., Rahmouni A., Meignan M., Clement O. Lymph node imaging: basic principles. Eur J Radiol 2006, 58:338-344.
71. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008, 38:1404-1413.
72. Mansel R.E., Khonji N.I., Clarke D. History, present status and future of sentinel node biopsy in breast cancer. Acta Oncol 2000, 39:265-268.
73. McCarthy J.R., Bhaumik J., Karver M.R., Erdem S.S., Weissleder R. Targeted nanoagents for the detection of cancers. Mol Oncol 2010, 4:511-528.
74. McElroy M., Hayashi K., Garmy-Susini B., Kaushal S., Varner J.A., Moossa A.R., et al. Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J Surg Res 2009, 151:68-73.
75. Mieog J.S.D., Troyan S.L., Hutteman M., Donohoe K.J., van der Vorst J.R., Stockdale A., et al. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 2011, 18:2483-2491.
76. Minamiya Y., Ito M., Katayose Y., Saito H., Imai K., Sato Y., et al. Intraoperative sentinel lymph node mapping using a new sterilizable magnetometer in patients with nonsmall cell lung cancer. Ann Thorac Surg 2006, 81:327-330.
77. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
78. Motomura K. Sentinel node biopsy for breast cancer: past, present, and future. Breast Cancer 2012, 1-9.
79. Motomura K., Inaji H., Komoike Y., Kasugai T., Noguchi S., Koyama H. Sentinel node biopsy guided by indocyanin green dye in breast cancer patients. Jpn J Clin Oncol 1999, 29:604-607.
80. Mouli S.K., Zhao L.C., Omary R.A., Thaxton C.S. Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors. Nat Rev Urol 2010, 7:84-93.
81. Muller M.G.S., van Leeuwen P.A.M., de Lange-de Klerk E.S.M., van Diest P.J., Pijpers R., Ferwerda C.C., et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 2001, 91:2401-2408.
82. Mumprecht V., Honer M., Vigl B., Proulx S.T., Trachsel E., Kaspar M., et al. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. Cancer Res 2010, 70:8842-8851.
83. Murali R., DeSilva C., McCarthy S.W., Thompson J.F., Scolyer R.A. Sentinel lymph nodes containing very small (<0.1mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative. Ann Surg Oncol 2012, 19:1089-1099.
84. Nagashima T., Sakakibara M., Nakano S., Tanabe N., Nakamura R., Nakatani Y., et al. Sentinel node micrometastasis and distant failure in breast cancer patients. Breast Cancer 2006, 13:186-191.
85. Nahrendorf M., Keliher E., Marinelli B., Waterman P., Feruglio P.F., Fexon L., et al. Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci U S A 2010, 107:7910-7915.
86. Nakagawa T., Minamiya Y., Katayose Y., Saito H., Taguchi K., Imano H., et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 2003, 126:563-567.
87. Ntziachristos V. Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods 2010, 7:603-614.
88. Oussoren C., Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 2001, 50:143-156.
89. Pan D., Pramanik M., Senpan A., Ghosh S., Wickline S.A., Wang L.V., et al. Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons. Biomaterials 2010, 31:4088-4093.
90. Pan D., Cai X., Yalaz C., Senpan A., Omanakuttan K., Wickline S.A., et al. Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles. ACS Nano 2012, 6:1260-1267.
91. Pankhurst Q. Endomagnetics: healthcare by sensing, moving and heating magnetic nanoparticles in the human body 2007, University College, London.
92. Parungo C.P., Ohnishi S., Kim S.W., Kim S., Laurence R.G., Soltesz E.G., et al. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 2005, 129:844-850.
93. Pinna N., Grancharov S., Beato P., Bonville P., Antonietti M., Niederberger M. Magnetite nanocrystals: nonaqueous synthesis, characterization, and solubility. Chem Mater 2005, 17:3044-3049.
94. Polom K., Murawa D., Rho Y.S., Nowaczyk P., Hunerbein M., Murawa P. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer 2011, 117:4812-4822.
95. Polom K., Murawa D., Nowaczyk P., Rho Y.S., Murawa P. Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green human serum albumin in comparison with gamma emitting radioactive colloid tracer. Eur J Surg Oncol 2012, 38:137-142.
96. Popovtzer R., Agrawal A., Kotov N.A., Popovtzer A., Balter J., Carey T.E., et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 2008, 8:4593-4596.
97. Rao D.A., Forrest M.L., Alani A.W.G., Kwon G.S., Robinson J.R. Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. J Pharm Sci 2010, 99:2018-2031.
98. Rasaneh S., Rajabi H., Babaei M.H., Akhlaghpoor S. MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles. J Nanopart Res 2011, 13:2285-2293.
99. Rzyman W., Hagen O.M., Dziadziuszko R., Kobierska-Gulida G., Karmolinski A., Lothe M.I., et al. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer. Eur J Surg Oncol 2006, 32:462-465.
100. Salhab M., Patani N., Mokbel K. Sentinel lymph node micrometastasis in human breast cancer: an update. Surg Oncol 2011, 20:e195-e206.
101. Shimizu S., Hosokawa M., Itoh K., Fujita M., Takahashi H., Shirato H. Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings. Int J Clin Oncol 2009, 14:421-425.
102. Shiozawa M., Lefor A., Hozumi Y., Kurihara K., Sata N., Yasuda Y., et al. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer. Breast Cancer 2013, 20:223-229.
103. Sobin L., Gospodarowicz M., Wittekind C. TNM classification of malignant tumours 2009, Wiley-Blackwell, Hoboken, NJ, USA. 7th ed.
104. Sondak V.K. Nonsentinel node metastases in melanoma: do they reflect the biology of the tumor, the lymph node or the surgeon?. Ann Surg Oncol 2009, 16:2965-2967.
105. Subramanian S., Dandekar P., Jain R., Pandey U., Samuel G., Hassan P.A., et al. Technetium-99m-labeled poly(DL-Lactide-co-Glycolide) nanoparticles as an alternative for sentinel lymph node imaging. Cancer Biother Radiopharm 2010, 25:637-644.
106. Sugi K., Fukuda M., Nakamura H., Kaneda Y. Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancer. Lung Cancer 2003, 39:37-40.
107. Sun C., Lee J.S.H., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008, 60:1252-1265.
108. Tafreshi N.K., Enkemann S.A., Bui M.M., Lloyd M.C., Abrahams D., Huynh A.S., et al. A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes. Cancer Res 2010, 71:1050-1059.
109. Tafreshi N.K., Bui M.M., Bishop K., Lloyd M.C., Enkemann S.A., Lopez A.S., et al. Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes. Clin Cancer Res 2012, 18:207-219.
110. Takeshita T., Tsuda H., Moriya T., Yamasaki T., Asakawa H., Ueda S., et al. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up. Ann Surg Oncol 2012, 19:1160-1166.
111. Thompson S.K., Ruszkiewicz A.R., Jamieson G.G., Sullivan T.R., Devitt P.G. Isolated tumor cells in esophageal cancer: implications for the surgeon and the pathologist. Ann Surg 2010, 252:299-306.
112. Thompson S.K., Bartholomeusz D., Jamieson G.G. Sentinel lymph node biopsy in esophageal cancer: should it be standard of care?. J Gastrointest Surg 2011, 15:1762-1768.
113. Tiffet O., Nicholson A.G., Khaddae A., Prevot N., Ladas G., Dubois F., et al. Feasibilitv of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radio isotopic and blue dye techniques. Chest 2005, 127:443-448.
114. Tsopelas C. Particle size analysis of Tc-99m-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application. J Nucl Med 2001, 42:460-466.
115. Tsopelas C., Bevington E., Kollias J., Shibli S., Farshid G., Coventry B., et al. Tc-99-Evans blue dye for mapping contiguous lymph node sequences and discriminating the sentinel lymph node in an ovine model. Ann Surg Oncol 2006, 13:692-700.
116. Turner R.R., Weaver D.L., Cserni G., Lester S.C., Hirsch K., Elashoff D.A., et al. Nodal stage classification for breast carcinoma: Improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol 2008, 26:258-263.
117. Van de Ven C., De Leyn P., Coosemans W., Van Raemdonck D., Lerut T. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg 1999, 15:769-773.
118. van der Vorst J.R., Schaafsma B.E., Verbeek F.P.R., Keereweer S., Jansen J.C., van der Velden L.-A., et al. Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients. Oral Oncol 2013, 49:15-19.
119. van Dongen G., Vosjan M. Immuno-positron emission tomography: shedding light on clinical antibody therapy. Cancer Biother Radiopharm 2010, 25:375-385.
120. van Dongen G.A.M.S., Visser G.W.M., MNL-d Hooge, De Vries E.G., Perk L.R. Immuno-PET: A navigator in monoclonal antibody development and applications. Oncologist 2007, 12:1379-1389.
121. Vanderveen H., Hoekstra O.S., Paul M.A., Cuesta M.A., Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994, 81:1769-1770.
122. Verel I., Visser G.W.M., van Dongen G.A. The promise of immuno-PET in radioimmunotherapy. J Nucl Med 2005, 46:164S-171S.
123. Viale G., Maiorano E., Mazzarol G., Zurrida S., Galimberti V., Luini A., et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001, 92:1378-1384.
124. Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 2012, 134:2139-2147.
125. Wallace A.M., Hoh C.K., Ellner S.J., Darrah D.D., Schulteis G., Vera D.R. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol 2007, 14:913-921.
126. Weissleder R., Pittet M.J. Imaging in the era of molecular oncology. Nature 2008, 452:580-589.
127. Yamashita S.-i., Tokuishi K., Anami K., Miyawaki M., Moroga T., Kamei M., et al. Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer. J Thorac Cardiovasc Surg 2011, 141:141-144.
128. Yamauchi K., Nagafuji H., Nakamura T., Sato T., Kohno N. Feasibility of ICG fluorescence-guided sentinel node biopsy in animal models using the HyperEye medical system. Ann Surg Oncol 2011, 18:2042-2047.